Wencewicz wins Sloan fellowship
The Alfred P. Sloan Foundation announced Feb. 15 that Timothy A. Wencewicz, assistant professor of chemistry in Arts & Sciences at Washington University in St. Louis, has been awarded a 2018 Sloan Research Fellowship. He is among 126 outstanding U.S. and Canadian researchers selected as fellowship recipients this year.
‘The process by which drugs are discovered and developed will be fundamentally different in the future’
Over the past several decades, Michael Kinch of Washington University in St. Louis says, the pharmaceutical industry has managed to dismantle itself. In a provocative series of articles and interviews, Kinch, the director of the Center for Research Innovation in Businessat the university, has been describing the history of this dismantling and its implications for the future of medicine.
$20 million gift establishes Taylor Family Institute for Innovative Psychiatric Research
Andrew and Barbara Taylor and the Crawford Taylor Foundation, the charity of the entire Jack C. Taylor family, have committed $20 million to the Department of Psychiatry at the School of Medicine to advance the science underlying the diagnosis and treatment of psychiatric illnesses. The gift creates the new Taylor Family Institute for Innovative Psychiatric Research.
New model suggests feared side effect of Alzheimer’s drugs is unlikely
The first trial of a new model for testing Alzheimer’s treatments has reassured researchers that a promising class of drugs does not exacerbate the disease if treatment is interrupted.
Washington University, Pfizer announce groundbreaking research collaboration
In a first-of-a-kind collaboration between academia and industry, Pfizer Inc. will give scientists at Washington University School of Medicine in St. Louis unprecedented access to information regarding more than 500 pharmaceuticals and pharmaceutical candidates in a partnership that focuses on discovering new uses for existing compounds.